Login
← Go Back
Shilpa Medicare
SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com
Stock Price vs Company Growth
1d
1.6%
1w
6.9%
1m
8.0%
3m
38.3%
6m
18.3%
1y
36.6%
5y
14.6%
10y
6.3%
all
17.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 435 1.6%
308
451
Company Overview
Sales
1,432 Cr
Growth: 9.2%
Profit after Tax
150 Cr
Growth: 9.3%
Mid Cap
8,504 Cr
P/E: 65.7x
Industry P/E: 30.4x
Fundamentals
Sales (Cr) ₹ 1,432
Growth 9.2%
EBITDA 27.3%
P/S 5.9x
Dividend 0.1%
P/E 65.7x
Book Value ₹ 129
PEG Ratio 7.2x
ROE 6.1%
P/B 3.4x
Shareholding Pattern
Institutions
Ta Fii Investors Fund
3.71 %
Tano Mauritius India Fvci Ii
2.43 %
Pivotal Enterprises Private Limited
2.35 %
Pivotal Business Managers Llp
1.75 %
Duro One Investments Limited
1.42 %
Promoters
Vishnukant Chaturbhuj Bhutada
7.81 %
Dharmavati Bhutada
7.61 %
Ravi Kumar Innani
4.91 %
Suraj Kumar Innani
4.88 %
Ramakant Innani
4.29 %
Others
Increase    Decrease    No change
Company Profile Detailed
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Belongs to (12 Indices) view more
Investors (148)
cohesion...
barclays...
vishnuka...
Followers (8)
nitin2
keerthi
deepak